// App-Quantinova.ai

P461 : Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease

Researchers

Presenter

  • S Travis

Principal Investigators

  • R Ungaro

  • A Blake

  • F Bhayat

  • T Card

Medical Centers

  • Oxford University Hospital, Oxford,

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Takeda International–UK Branch, London, UK

  • Takeda Development Center Americas Inc., Cambridge, USA

  • University of Nottingham, Nottingham, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved